Insurer denial rates, appeal outcomes by treatment and condition, and appeal rights lookups.
Inferido de los transportes que declara este listado (streamable-http). Que un cliente no aparezca aquí no significa que se haya descartado: simplemente Forge no puede confirmarlo.
La verificación confirma la identidad del publicador (la propiedad del repo), no la seguridad del código. El análisis de seguridad cubre los CVE conocidos y los scripts de instalación sospechosos.
Leído de un handshake MCP real initialize → tools/list contra el endpoint declarado. No se invocó ninguna herramienta: tools/list es la llamada de introspección de solo lectura que el protocolo define para esto. Refleja lo que el servidor anunciaba en ese momento; un endpoint alojado no está fijado a ninguna versión y puede cambiar sin avisar.
https://www.coverage-rights.com/api/mcp9 herramientas · 246 mslist_insurersList tracked U.S. health insurers with whether verified CMS-0057-F prior-authorization metrics are available for each.List tracked U.S. health insurers with whether verified CMS-0057-F prior-authorization metrics are available for each.
No se publicó ningún esquema de entrada para esta herramienta.
get_insurer_metricsGet an insurer's verified CY2025 prior-authorization metrics (denial rate, appeal overturn rate, decision times) from its own CMS-0057-F disclosure, plus contract/plan-level rows where collected. Includes source URLs and scope notes.Get an insurer's verified CY2025 prior-authorization metrics (denial rate, appeal overturn rate, decision times) from its own CMS-0057-F disclosure, plus contract/plan-level rows where collected. Includes source URLs and scope notes.
| Parámetro | Tipo | Descripción |
|---|---|---|
| slug* | string | Insurer slug from list_insurers, e.g. 'unitedhealthcare' |
rank_denial_ratesInsurer prior-authorization denial rates (CY2025), ranked only within compatible reporting cohorts. Each row includes its cohort, rank within that cohort, exact source scope, calculation method, and source link. Never compare ranks across cohorts.Insurer prior-authorization denial rates (CY2025), ranked only within compatible reporting cohorts. Each row includes its cohort, rank within that cohort, exact source scope, calculation method, and source link. Never compare ranks across cohorts.
No se publicó ningún esquema de entrada para esta herramienta.
get_treatment_outcomesExternal-review outcomes for a treatment: how often insurer denials of this treatment/drug/procedure were overturned by independent reviewers (42,749 published CA IMR decisions, 2001–2026). Accepts a category slug (e.g. 'pharmacy') or specific treatment slug (e.g. 'zepbound', 'speech-therapy').External-review outcomes for a treatment: how often insurer denials of this treatment/drug/procedure were overturned by independent reviewers (42,749 published CA IMR decisions, 2001–2026). Accepts a category slug (e.g. 'pharmacy') or specific treatment slug (e.g. 'zepbound', 'speech-therapy').
| Parámetro | Tipo | Descripción |
|---|---|---|
| slug* | string | Treatment slug, e.g. 'zepbound', 'pharmacy', 'speech-therapy'. Use search_outcomes to find slugs. |
get_condition_outcomesExternal-review outcomes for a medical condition: how often insurance denials involving this condition were overturned, plus the most-fought treatments for it.External-review outcomes for a medical condition: how often insurance denials involving this condition were overturned, plus the most-fought treatments for it.
| Parámetro | Tipo | Descripción |
|---|---|---|
| slug* | string | Condition slug, e.g. 'obesity', 'autism', 'hepatitis-c' |
search_outcomesSearch treatments (categories + specific drugs/procedures) and conditions by name. Returns slugs for get_treatment_outcomes / get_condition_outcomes plus headline overturn rates.Search treatments (categories + specific drugs/procedures) and conditions by name. Returns slugs for get_treatment_outcomes / get_condition_outcomes plus headline overturn rates.
| Parámetro | Tipo | Descripción |
|---|---|---|
| query* | string | Search text, e.g. 'wegovy', 'back pain', 'imaging' |
| limit | integer | Max results per type (default 10) |
get_appeal_rightsDeterministically resolve the governing appeal route, missing facts, filing recipient, deadlines, current external-review status, and verified grounds. Distinguishes Original Medicare, Medicare Advantage medical benefits, Part D pharmacy benefits, employer funding/governance, ACA, Medicaid, FEHB, T…Deterministically resolve the governing appeal route, missing facts, filing recipient, deadlines, current external-review status, and verified grounds. Distinguishes Original Medicare, Medicare Advantage medical benefits, Part D pharmacy benefits, employer funding/governance, ACA, Medicaid, FEHB, T…
| Parámetro | Tipo | Descripción |
|---|---|---|
| program* | string | Plan type |
| denial_reason* | string | Denial reason category. Use 'prescription-drug' for medication denials — formulary exclusion, step therapy, quantity limits, or drug prior authorization — whic… |
| state | string | Two-letter state code, e.g. 'ca' |
| insurer_slug | string | Insurer slug for insurer-specific stats |
| employer_type | string | Required to resolve job-based coverage |
| funding_status | string | Required to resolve job-based state versus federal governance |
| drug_channel | string | For a drug denial, whether the medical or pharmacy benefit applies |
| regulatory_marker | string | — |
| regulatory_state_basis | string | — |
| appeal_stage | string | — |
| current_status | string | — |
get_drug_playbookDrug-specific denial patterns and appeal strategy for the medications plans fight hardest over: GLP-1s (Wegovy, Zepbound, Mounjaro, Ozempic, Saxenda) and IBD biologics (Humira, Skyrizi, Stelara, Entyvio, Remicade, Rinvoq). Returns FDA-approved indications stated conservatively, why plans deny that…Drug-specific denial patterns and appeal strategy for the medications plans fight hardest over: GLP-1s (Wegovy, Zepbound, Mounjaro, Ozempic, Saxenda) and IBD biologics (Humira, Skyrizi, Stelara, Entyvio, Remicade, Rinvoq). Returns FDA-approved indications stated conservatively, why plans deny that…
| Parámetro | Tipo | Descripción |
|---|---|---|
| drug* | string | Brand or generic drug name, e.g. 'Zepbound', 'ustekinumab' |
get_state_external_reviewHow a state's external review process works: filing deadline, regulator contact, and key facts. Verified detail currently covers 10 states (CA, TX, FL, NY, PA, IL, OH, GA, NC, MI); other states return the covered list.How a state's external review process works: filing deadline, regulator contact, and key facts. Verified detail currently covers 10 states (CA, TX, FL, NY, PA, IL, OH, GA, NC, MI); other states return the covered list.
| Parámetro | Tipo | Descripción |
|---|---|---|
| state* | string | Two-letter state code, e.g. 'ca', 'ny', 'fl' |
9 de 9 herramientas publicaron una descripción.
Los nombres y descripciones de las herramientas los escribe el publicador y se muestran literalmente como texto inerte. Son las cadenas que un cliente MCP pasa al modelo, así que Forge las analiza en busca de patrones de inyección de prompts — cualquier hallazgo aparece junto al análisis de seguridad de arriba. «Privilegiada» es una coincidencia de palabra clave en el nombre de la herramienta, no una auditoría de lo que hace: un nombre inofensivo puede hacer cualquier cosa.
Insurer denial rates, appeal outcomes by treatment and condition, and appeal rights lookups.
Los nombres enlazados abren el índice de Forge con todas las entradas que se observó que exponen esa herramienta. Ver todas las herramientas indexadas.
Esta entrada no publica ningún paquete de npm, así que Forge no tiene un árbol de dependencias para ella. Es una carencia de cobertura, no una afirmación de que no tenga dependencias.